Sebi also said the five entities failed to handle the price-sensitive information properly. Information on the deal was shared with Anand Piramal, who is neither an employee nor a director on the board (although he is part of the promoter group). In May 2010, Piramal sold its domestic healthcare business to Abbott for a consideration of $3.72 billion and announced the plan to stock exchanges on 21 May 2010.